Westminster Health Forum

Next steps for combating antimicrobial resistance - funding, prevention and research priorities

Morning, Wednesday, 6th February 2019

Central London

THIS EVENT IS CPD CERTIFIED



This timely seminar focuses on latest developments in tackling antimicrobial resistance (AMR) in England - with the 2013-2018 UK AMR Strategy due to complete soon.


It comes as it is announced that AMR will be central to the forthcoming 10-year plan for the NHS - with the plan set to focus on prevention, funding and research.


With a refreshed AMR strategy expected to include a 20-year vision and 5-year action plans, delegates will assess the way forward for delivery to ensure that key aims are met.


Delegates will also discuss the next steps for strengthening international collaboration on AMR, which is highlighted as a main strand of the UK biological security strategy - and follows £30m funding made available by the Government to support the global fight against AMR.


They will examine the measures being taken by industry and healthcare professionals to encourage the responsible use of antibiotics, including the impact of reimbursement models, and the use of antibiotics within farming and agriculture - looking at potential ways forward for developing a holistic approach to human, animal and environmental health.  


Further sessions will look at the progress of research being conducted to accelerate new forms of treatment for drug resistant bacterial infections - including the impact of the new £32m funding made available for AMR research and the £10m Small Business Research Initiative to address AMR - as well as how diagnostics can be better utilised to guide treatment decisions. 



Guest of Honour

Professor Dame Sally Davies

Chief Medical Officer, Department of Health and Social Care (subject to diary)

Supported by

Guest of Honour

Professor Dame Sally Davies

Chief Medical Officer, Department of Health and Social Care (subject to diary)

Keynote Speaker

Professor Alan Johnson

Head, Department of HCAI and AMR National Infection Service, Public Health England

Speakers

Dr Anita Sharma

GP and Clinical Director, Vascular and Medicine Optimisation, NHS Oldham Clinical Commissioning Group

Professor Hilary Thomas

Chief Medical Adviser and Member, Centre of Excellence in Healthcare and Life Sciences, KPMG

James Anderson

Chair, Antibiotic Network, ABPI and Head of Corporate Government Affairs, GSK

Richard Griffiths

Chief Executive, British Poultry Council

Jonathan Pearce

Head of Infections and Immunity, Medical Research Council

Senior speaker confirmed from the National Institute for Biological Standards and Control

Cóilín Nunan

Scientific Advisor, Alliance to Save our Antibiotics